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Ionotropic glutamate receptors (iGluRs) are proteins that allow for the propagation of 
electrical signals in neurons. These proteins work by opening a transmembrane pore in 
response to the binding of the excitatory neurotransmitter glutamate by an extracellular 
ligand binding domain (LBD). Here we investigate how the free energy landscape of a 
prokaryotic analog to these eukaryotic iGluRs, GluR0, changes in response to the 
binding of various ligands. We find a very flexible LBD, which clamps down in response 
to ligand binding. We present potential of mean force (PMF) maps of the GluR0 LBD in 
apo, glutamate, and serine bound forms. In addition to our computational work on 
GluR0, experiments were done to observe shape changes in AMPA receptor LBD 
dimers. Analytical ultracentrifugation (AUC) was performed on two GluA2 mutants, one 
biased towards the desensitized state, the other not. We performed sedimentation 
velocity experiments on the two mutants, and use the c(s) fits to observe changes in the 
f/f0 values. Finally we used principal component analysis (PCA) to analyze the 
trajectories of molecular dynamics simulations in NMDA receptors. Analysis of the 
trajectories shows how the LBD explores the ensemble of conformations available to it, 
and how that changes upon ligand binding. 
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Chapter 1: Introduction to Ionotropic Glutamate Receptors 
1.1: Ionotropic Glutamate Receptors and Their Role in Neuronal Signaling 
 
The nervous system is a complex network of nerves and neurons that transmit electrical 
signals across the body. Synapses exist to allow neurons to convert electrical signals 
into chemical signals, and then back into electrical signals. This is a four step process 
that begins with a flood of calcium into the presynaptic neurons. This triggers an 
exocytosis of vesicles carrying neurotransmitters such as glutamate or acetylcholine. 
These neurotransmitters enter the synaptic cleft, where they bind to their target 
receptor. This binding induces structural changes in these receptors, which allow ions to 
flow through the membrane [Figure 1] (Purves et al. 2001). In the mammalian system 
the majority of these excitatory interactions are mediated by the amino acid glutamate 
(Institute of Medicine 2011). Correspondingly, there is a class of transmembrane 
receptors, ionotropic glutamate receptors (iGluRs), which bind glutamate in order to 
propagate these signals. The structure and function of these receptors are crucial to 
proper brain development, learning, and memory formation. These receptors are 
assosciated with multiple neurological diseases and disorders, including Alzheimer’s, 
depression, and traumatic brain injury (Karakas et al. 2015). 
 
1.2 Structure of Ionotropic Glutamate Receptors 
 
iGluRs can be divided into four families, that can be distinguished by their response to 




isoxazole propionic acid (AMPA) are called AMPA receptors, and follow a GluA* naming 
convention. Those that respond to N-methyl-D-aspartate are called NMDA receptors, 
and obey a GluN* naming convention. Those that respond to kainate are called kainate 
receptors, and obey a GluK* naming convention. Finally there are the delta receptors, 
which although not actually glutamate binding receptors, show ~18%-25% sequence 
homology with the NMDA, AMPA, and kainate receptors and are involved in 
synaptogenesis and synaptic plasticity (Dingledine et al. 1999). Although they share a 
similar overall structure, these receptor subtypes show differences in pharmacology, 
unique activation, deactivation and desensitization kinetics, selective permeability, 
single-channel properties, and the unique roles they play in different forms of both 
neuronal and glial signaling (Armstrong et al. 2000). 
iGluRs share a modular structure consisting of four distinct domains: an amino 
terminal domain (ATD), a transmembrane domain (TMD), a ligand binding domain 
(LBD), and a carboxylic terminal domain (CTD) [Figures 3 and 4].  
The amino terminal domain sits outside the cell as a clamshell-like structure that 
is thought to aid in the formation of higher order complexes in all families of glutamate 
receptors (Bigge et al. 1999). It also interacts with extracellular proteins to aid with the 
organization of iGluRs within the membrane (Furukawa 2012). It is not necessary for the 
function of the receptor in the AMPA and kainate families, with both forming functional 
receptors in the absence of this amino terminal domain (Furukawa 2012). In the NMDA 
receptor however, it has two clear and defined functions. The first is tuning the 
probability of the NMDAR LBD being in the open state (Gielen et al. 2009; Yuan et al. 




a binding site for zinc, which lowers channel activity in the pore (Choi & Lipton, 1999; 
Low et al. 2000). 
The LBD is a bi-lobed glutamate binding pocket. The first lobe (D1) is adjacent to 
the M1 helix. The second lobe (D2) of this binding domain comes in between the M3 
and M4 helices [Figure 4]. It is here that the conformational changes associated with 
gating begin. The binding of an agonist ligand in the LBD induces a conformational 
change that is transmitted through peptide linkers to the TMD. This change opens the 
pore and allows depolarization to occur (Krieger et al. 2015). In all AMPA and Kainate 
receptors, this agonist is glutamate. In NMDA receptors two of the ligand binding 
domains, GluN1 and GluN3, instead bind glycine and D-serine (Furukawa et al. 2003, 
Yao et al. 2008). So far, crystal structures of iGluR dimer have all been constructed as 
homodimers, with the exception of the NMDA receptor, which has been found as a 
GluN1/GluN2A heterodimer (Furukawa et al. 2005). It has been shown that interactions 
at this dimer interface affect the extent of desensitization and the speed with which the 
receptor deactivates (Schauder et al. 2013, Armstrong et al. 2006). 
The TMD consists of three transmembrane helices (M1, M3, and M4) along with 
a cytoplasm facing transmembrane re-entrant loop (M2). The M1, M3, and M4 helices 
combine to form a fourfold symmetric pore that resembles an inverted potassium 
channel (Traynelis et al. 2005). This TMD is selective for the cations Na+, K+ and Ca2+. 
In NMDA receptors, this TMD is blocked by a Mg2+ under physiological conditions, and 
must be removed by depolorization before ions can flow through (Blanke et al 2009). 
The TMD is attached to the CTD, which interacts with intracellular proteins to control the 




 Functional glutamate receptors are assembled as dimers of dimers to form a 
tetrameric complex. In the all of the AMPA ,GluA(1-4), and most of the kainate, GluK(1-
3), the subunits can form both homo and hetero tetramers (Dingledine et al. 1999). The 
last two kainate receptors, GluK4 and GluK5, both require two of the other kainate 
receptors to form a functional receptor (Dingledine et al. 1999). NMDA receptors are 
unique in that they are all obligate heterotetramers. They assemble by combining a 
glutamate binding domain, GluN2, with one of two glycine binding domains, either 
GluN1 or GluN3 (Dingledine et al. 1999).  
 
1.3 GluR0, a Prokaryotic Glutamate Receptor 
 
GluR0 is a hypothetical precursor to eukaryotic glutamate receptors, discovered in the 
freshwater cyanobacteria Synechocystis PCC 6803 (Chen et al. 1999). This protein was 
found by performing a BLAST (Basic Local Alignment Search Tool) search on the 
Synechocystis genome with the first three membrane-associated segments of the rat 
AMPA receptor, GluA2. This search turned up a protein similar to the eukaryotic iGluRs, 
but with some key differences [Figure 5]. To begin with, while it contains regions similar 
to the S1 and S2 sequences of the iGluR ligand binding domain, and was subsequently 
found to be able to bind glutamate, it lacked any response to AMPA, NMDA, or kainate 
(Chen et al. 1999). Unlike the eukaryotic glutamate receptors though, GluR0 does 
respond to L-serine, L-alpha-amino adipic acid, and D,L-alpha-aminopimelic acid (Chen 
et all. 1999). Crystal structures of both the serine and glutamate bound states reveal 




(Mayer et al. 2001). In the case of serine, GluR0 requires additional water molecules to 
occupy the binding cleft in order to bind serine (Mayer et al. 2001). In the case of 
glutamate, the ligand occupies an ‘extended’ conformation, with its γ-carboxyl pointed 
towards Asn51 in the upper lobe (Mayer et al. 2001) [Figure 6]. This is in contrast with 
the eukaryotic iGluRs which adopt a ‘bent’ conformation, γ-carboxyl pointed down 
towards the lower lobe [Figure 6] (Mayer et al.2001). It is speculated by Mayer that, due 
to the difference in how GluR0 and eukaryotic iGluRs bind ligands, that the 
conformational changes induced by the ligands should also differ (Mayer et al. 2001).  
The transmembrane domain of GluR0 is also unique. Rather than the Na+, K+ 
and Ca2+ ions that eukaryotic gluRs allow through, GluR0 contains a gating region and 
transmembrane topology more similar to the potassium channel KcsA, and thus only 
lets through potassium ions (Chen et al. 1999, Yalini et al. 2003). These ion channels 
show many spontaneous openings, even in the unliganded state (Cheng et al. 2002). 
These channels have slower activation kinetics than the eukaryotic iGluRs, GluR0 being 
(290 ± 15 ms) versus the GluA2 rise time of (18 ± 3 ms) (Chen et al. 1999). The 
structural basis for slower kinetics and spontaneous activation is currently unknown. 
 
1.4 Overview of Data Presented Here 
 
The central question of this thesis is in the similarities and differences in large-scale 
conformational transitions exhibited by the LBDs of these iGluRs. Since the LBD is the 
‘control center’ of the receptor understanding its molecular mechanics can help us 




differences among the iGluRs. This focus on motion serves to complement the multiple 
static structures currently available of the various iGluRs, obtained through means such 
as X-ray crystallography or electron microscopy. Using a combination of computational 
and experimental techniques we can observe both the ensemble of states available to 
these LBDs, how the binding of ligands affects the closure of the LBD, and the motions 
by which the LBD navigates that ensemble.  
 In Chapter 2 we focus on simulations of the monomeric ligand binding domain of 
GluR0. Here we begin with crystal structure of the LBD in various binding states: apo, 
glutamate bound, and serine bound. Using umbrella sampling we show which states, 
either open or closed, that the LBD can access in either the apo or ligand bound state, 
and we see how the change in glutamate binding modes between GluR0 and eukaryotic 
iGluRs effects the changes observed upon ligand binding in the LBDs. In contrast with 
the eukaryotic receptors, which have been studied using dynamic methods such as 
NMR or FRET, GluR0 has not been subject to the same level of investigation. 
Interestingly, despite the lack of an open apo crystal structure, we show that this state 
should be accessible to the GluR0 LBD. Having generated an ensemble of structures 
and knowing the energetics associated with each of those structures, we attempted to 
use small angle X-ray scattering (SAXS) to see if our PMF could predict experimental 
SAXS curves of the GluR0 monomer. Finally, we use principal component analysis 
(PCA) to see how the LBD explores the conformations available to it. We show that 
there is a rearrangement of principal components (PCs) that occurs upon ligand binding 




 Chapter 3 looks at the structural rearrangements that occur during 
desensitization in the AMPA receptor GluA2. We construct modified versions of the 
GluA2 LBD, attaching a linker region to allow for the creation of cysteine linked dimers. 
We made two variants of the GluA2 LBD, one with a mutation designed to promote 
dimerization, one with a set of mutations designed to inhibit it. We then use analytical 
ultracentrifugation to observe the effect of these mutations on the shape of the GluA2 
dimers. 
Chapter 4 uses PCA to analyze the motions that various GluNs use to traverse 
their ensemble. We perform PCA on multiple GluN ligand binding domains including 
both glutamate and glycine binding domains. We show how these modes change upon 
ligand binding, and how the LBD samples the ensemble of structures available to it. We 
then models these motions onto the full length NMDA receptor, and see how they affect 




































Fig 3. Full length structures for the NMDA, AMPA, and Kainate structures 
respectively.  
Structures of three main iGluRs. From left to right: AMPA receptor in the competitive 
antagonist MPQX bound state (PDB: 5KK2), NMDA receptor in the glycine/glutamate 
bound state (PDB: 5IOU), and kainate receptor in the presence of the agonist 2S,4R-4-
methylglutamate (PDB: 5KUF). All iGluRs assemble as dimers of dimers, with the 
AMPA and kainate shown as homomers, while the NMDAR is a heteromer. Each iGluR 














Fig 6. Schematic of the differences in glutamate binding in GluR0 and GluA2 
How glutamate, colored green, binds within the cleft of the the ligand binding domain for 
GluA2 (PDB: 4Z0I, colored blue) and GluR0 (PDB: 1ii5, colored red) respectively. In 
GluA2, on the left, glutamate adopts a ‘relaxed’ conformation, and in GluR0 the 
glutamate adopts an ‘extended’ conformation. This change means that the γ-carboxy of 




Chapter 2: Computational and Experimental Characterization of GluR0 
Reproduced in part from: 
Ionotropic Glutamate Receptor Technologies, Neuromethods vol. 106 chap 9 
DOI 10.1007/978-1-4939-2812-5_9, Springer Science+Business Media New York 2016 
by 
Alvin Yu, Tyler Wied, John Belcher, and Albert Y. Lau 
 
 
Molecular Dynamics (MD) simulations are a tool for investigation biological 
macromolecules beyond the static structures of x-ray crystallography and electron 
microscopy. This ability to see these molecules in motion allows one to explore 
conformations of the macromolecule that are unreachable by experimental methods 
alone. Within the case of ionotropic glutamate receptors (iGluRs), this technique allows 
us to study the complex network of actions and interactions that govern the function of 
the receptor. This chapter briefly introduces the theory behind these MD simulations, 
the Umbrella Sampling technique, and their use on the GluR0 LBD. The results of these 
computational techniques are then tested using Small Angle X-Ray Scattering (SAXS) 
 
2.1 Molecular Dynamics Theory 
 
To explain a molecular dynamics simulation is relatively straightforward. Newton’s laws 
of motion are used to evolve the positions and velocities of a system of atoms. For a 
two-atom system, this is a relatively trivial task. For an 80,000 atom system, this 
requires advanced computing resources. Regardless of the size of the system or the 
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software package chosen to run it on, there are commonalities within the force fields 
that will be applied to the atoms. Most molecular dynamics force fields will include the 
following terms: � =  ∑ � − + ∑ �� � − �� + ∑ �ϕℎ [ + cos ϕ − δ ] +
 ∑ �� � − �� � ℎ +  ∑ { �� � +  � (� � �� ) −   (� � �� )6}               (1) 
The ‘bonded’ terms are the bonds, angles, dihedrals, and improper dihedrals. The first 
term contains b, the bond distance, b0, the equilibrium value for bond distance, and Kb, 
the force constant. The angle term is formatted similarly, with θ, the valence angle, θ0, 
the equilibrium value, and Kθ, the force constant for the angle. The dihedral terms are 
represented by a force constant, �ϕ, the dihedral angle, ϕ, and the multiplicity and 
phase for the dihedral angle, n and δ respectively. The improper dihedral term, a 
measure of out of plane distortion, contains the angle χ, its equilibrium value χ0, and the 
force constant Kχ. The ‘nonbonded’ terms are the electrostatic interactions treated using 
a Coulombic term and the interatomic repulsion and dispersion interactions treated 
using a Lennard-Jones “6-12” term. In these non-bonded interactions qi and qj are the 
partial atomic charges on atoms i and j; ε is the dielectric constant; rij is the distance 
between atoms i and j; and the Lennard-Jones potential well depth and minimum 
interaction radius are εij and Rmin,ij. 
 The above parameters describe all that is necessary to run a “brute force” 
simulation. However, complex systems with high energy barriers such as an iGluR 
ligand binding domain will require more tools to fully explore the energy landscape in 
ordinary time. Numerous methods have been developed to deal with these limitations, 




2.2 Umbrella Sampling 
 
Umbrella sampling begins with the choice of an order parameter. A well-chosen order 
parameter is key to a successful umbrella sampling simulation. In theory anything could 
be an order parameter, a distance, an angle, or a deviation from a reference state. A 
well-chosen order parameter will traverse the conformational states of the protein, and 
differentiate between these states. Choosing an appropriate order parameter for a given 
system often requires a mix of physical intuition and prior knowledge of the chemical 
process under consideration. 
 Once an order parameter, ξ, is chosen, our quantity of interest is the free energy, 
or potential of mean force (PMF), W(ξ), along ξ: ξ = ξ∗ − �  [ ξξ∗ ]                     (2) 
 where ξ∗ is an arbitrary reference value, ρ(ξ)  is the Boltzmann weighted average 
distribution function along ξ, kb is Boltzmann’s constant, and T is the temperature.  
Although in principle it would be possible to arrive at W(ξ) by running brute force 
simulations, in practice energy barriers can impede sampling along ξ. In the finite 
amount of time that a simulation can run, low energy regions would be highly sampled, 
while higher energy regions would be sampled rarely, and states on the other side of 
barriers higher than kb T may not be sampled at all [Figure 1]. This poor sampling would 
lead to unreliable statistics from which to calculate the PMF. One of the solutions to this 
lack of sampling is the umbrella sampling technique, developed by Torrie and Valleau. 
In this technique, ‘windows’ are created along a reaction coordinate ξ. These windows 
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are biased towards a reference value of ξ through the use of a harmonic restraining 
potential, with the complete set of ξ values spanning the conformational space of 
interest. The effect of this bias is to ensure sampling in regions that may not be 
energetically connected.  
It is possible to compute the unbiased PMF of an individual sampling window 
from the biased probability distribution through the following: 
ξ =  ξ∗ −  [ ��∗ ] − � +                           
Where  is the free energy associated with introducing the window potential, ξ , and �  is the biased distribution function generated by the i-th window. In the one 
window case,  can be left undetermined, since the probability distribution can only 
determine the PMF up to a constant. In the multi-window case however, we have 
different weights to each of our different distributions, and must figure out how to weight 
them accordingly. 
Numerous approaches have been developed to accomplish this task (Roux 
1995, Kastner 2011). We will discuss only one of these approaches, the weighted 
histogram analysis method (WHAM) (Kumar et al. 1992), although other valid 
approaches are certainly available. WHAM works through two equations, known as the 
WHAM equations: 
      ξ  =   ∑ = ξ  x [∑ −[� ξ −� ]/ ��= ]−      
and 
                −��/ �� =    ∫ ξ  −�� ξ /kB� ξ    
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Where N is the number of simulations, and  are the number of sampling data points 
used to generate each biased distribution function.  Equations (4) and (5), are 
interdependent, with  and ξ  as unknowns. WHAM uses an iterative process to 
solve for ξ  and  until self-consistency is achieved. The equations above are 
written in terms of a one-dimensional ξ. The approach can be applied to multi-
dimensional scenarios as well.  
 
2.3 Umbrella Sampling of GluR0 
 
This study used all atom molecular simulations, combined with umbrella sampling, to 
reveal the energetics of opening and closing of the GluR0 S1S2 ligand binding domain, 
in its apo, serine, and glutamate bound forms. The study began with crystal structures 
from the Mayer lab, of GluR0 in all three of the above states. Missing sidechains were 
built in using SCWRL, and missing backbone atoms using MODELLER (Wang et al. 
2008, Sali et al 1993, Fiser et al. 2000). Initial configurations were generated using a 
targeted MD simulation, in which the two lobes of the LBD were moved apart in vacuum 
along the chosen order parameters, �  and �  For the GluR0 simulation �  represents 
the distance between the center of mass of the 54th and 55th residues and the 124th, 
125th, and 126th. �  represents the distance between the center of mass of the 13th, 
14th and 17th residues and the center of mass for the 143rd and 144th residues [Figure 
2]. Previous studies by the Lau lab have used similar order parameters on iGluR LBDs, 
yielding good results. Starting from the initial closed conformation, new windows were 
created by incrementally increasing the values of �  and �  in vacuum. After this initial 
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setup was complete, the windows were solvated with explicit waters, and 150 mM NaCl. 
Additional sodium and chlorine atoms were then added to neutralize the charge of the 
protein and its ligands. Any crystallographically observed waters were kept in their 
original positions. After this setup, the system must then be equilibrated before 
production runs can begin. First, the protein and ligand atoms are held fixed while 
dynamics are carried out on the solvent. Next, dynamics are carried out in the presence 
of stabilizing restraining potentials on the protein and ligand. These restraints are 
gradually reduced over the course of the equilibration, which is carried out in the 
constant atom number, volume, and temperature (NVT) ensemble. Finally, after these 
restraints have been removed, the simulation is transitioned to a constant pressure 
(NPT) ensemble. In all steps of the equilibration involving non-fixed protein and ligand 
atoms, the umbrella restraints on �  and �  are also applied, there is a restraining 
potential keeping the ligand tethered to the binding pocket, as well as weak restraints on 
the COM of three regions in the core of lobe 1. The latter restraint, which does not 
hinder inter-lobe dynamics, prevents translation and rotation of the protein during the 
production phase of the simulations. 
 The simulations enter production phase after equilibration has completed. Here, 
the values for �  and �  in each window i are recorded, which contribute to the biased 
distribution function � , � . For NPT runs in GluR0 we used a two femtosecond 
timestep, and ran 102 windows for 1.2 ns each, yielding ~120 ns of simulation time.  




 We start with apo PMF in figure 3. This PMF features a broad free energy basin, 
with the vast majority of the PMF falling below 2 kcal/mol. This indicates a high degree 
of conformational flexibility in the absence of ligand. While the only apo crystal structure 
of GluR0 shows it in the closed state, our PMF shows that it does have access to open 
conformations in its apo form, with a free energy basin below 1 kcal/mol available at (� , � ) = (12.5, 13 Å).  The global free energy minimum is located at. This closed state 
minimum may explain the random activation observed in electrophysiology experiments 
(Chen et al. 1999). 
As expected, the glu-bound LBD PMF features an energy basin that is narrower, 
indicating stabilized closed cleft conformations [Figure 4]. The global free energy 
minimum is located at (� , � ) = (8.1, 10.4 Å). The minima for both the apo and 
glutamate bound forms of the PMF are relatively close. GluR0 only shows a negligible 
difference between the apo and ligand bound PMFs. This closeness suggests that 
glutamate binding works through an conformational selection mechanism, where a 
subset of previously accessible structures are stabilized by ligand binding, rather than 
induced fit, where ligand binding stabilizes previously less favored energetic states 
(Freire, 1998; Ma et al., 1999; Monod et al., 1965). This is in contrast with previously 
done work on the GluA2 ligand binding domain. In the case of GluA2, the minima 
moves ~4.1 Å between the apo and ligand bound PMFs (Yao et al 2014). 
The serine bound PMF is somewhere in between the apo and glutamate bound 
forms [Figure 5]. A much more stable closed conformation as compared to apo form, 
but not as dramatically closed as the glutamate bound version. It features a similar 
minima at (� , � ) =  (7.5, 10.2 Å). The PMF shows a LBD that has access to its open 
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state, even in this ligand bound form. The serine bound LBD shows a stable open 
conformation, relative to the glutamate bound PMF. This accessible open conformation 
may explain why serine produces weaker and slower activations compared to glutamate 
in previous electrophysiology experiments (Chen et al. 1999). 
 
2.4 Principal Component Analysis of GluR0 
 
While hinge bending motions that move diagonally across the PMF, are of great 
importance to the activation of iGluRs, additional motions may contribute to how the 
LBD explores the ensemble. Principal Component Analysis (PCA) allows us to observe 
motions outside of hingebending that may contribute to how the LBD explores the 
ensemble of states available to it. PCA calculations involve the diagonalization of the 
covariance matrix �  of positional deviations among an ensemble of protein structures 
(Grossfield et al. 2009, Levy et al 1984): � =  ���(� , � ) = �[ � −  μ (� − μ )]   
Where �  represents a specific Cα coordinate, � is an operator that denotes the mean 
of its argument, and μ  is the average positional value for the i-th Cα. The ensemble, 
generated separately for the GluR0 LBD in either the apo- or glutamate/serine-bound 
state, consists of protein conformers from all umbrella sampling windows in which W(� , � ) is less than 2 kcal/mol. These conformers are then weighted in such a way that all 
conformers with an energy less than 1 kcal/mol are counted 5 times and those with an 
energy between 1 kcal/mol and 2 kcal/mol are counted only once, this crude weighting 
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allows us to approximate the actual energetics associated with the ensemble. The ratio 
of two Boltzmann weighted states is: 
�  �  = � −���   (7) 
Where F(x) is the frequency of x and Ei is the energy of the i-th state. For a delta of one 
and a kT of .5922, this ratio is roughly five to one. Only Cα coordinates were used in the 
calculations. All conformers were first superimposed onto lobe 1 of a reference 
structure, PDBid 1IIT, 1II5, and 1IIW respectively (Mayer et al. 2001), using a selection 
of Cα atoms that excludes flexible loops. Next, the lobe 1 Cα atoms of the reference 
structure were joined to the lobe 2 Cα atoms of each simulated conformer to construct 
an ensemble of pseudo-rigid-body structures. The ensembles for the apo LBD 
contained 32797 structures, the serine bound contained 7979 structures, and the 
glutamate bound had 9958 structures. These structures were stitched into pseudo 
trajectories, and PCA performed using the Bio3d package in R (Grant et al. 2006). The 
axes of rotation characterizing PC1–PC3 were calculated using the DomainSelect 
method provided by the DynDom server (Hayward et al. 1998). Endpoint coordinates 
were generated using Bio3D. Lobe 1 is the ‘‘fixed’’ domain, and lobe 2 is the ‘‘moving’’ 
domain. For GluR0, lobe 1 is defined as residues 1-94 and 189-235, and lobe 2 is 
defined as residues 95–188. For the apo and serine bound forms of GluR0 the PCs that 
define interlobe transitions are similar to those found in the GluA2 and GluN LBDs (Yao 
et al. 2013). The first PC in the apo form is a hingebinding motion that accounts for the 
largest portion of the variance [Figure 6, Table 1]. PC2 and PC3 also follow the 
precedent seen in the GluA2 and GluN results, and can be described as a rocking and 
twisting motion [Figure 6].  
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The glutamate bound version of the LBD reverses the order of the first and 
second PCs, with PC1 showing a rocking motion, and PC1 hingebending [Figure 7, 
Table 1]. PC3 remains the same.  
The Serine bound PCs reflect those seen in the apo state, with hinge-bending 
once again being the dominant motion [Figure 8, Table 1]. PC2 and PC3 are also the 
same, sharing the rocking and twisting motions with the apo form of the LBD. 
 
2.5 Error Analysis 
 
Uncertainty for the PMFs was calculated using block averaging (Zhu et al 2012). Each 
set of � , �  values for each window was split into 10 blocks of equal size. WHAM was 
used to calculate a PMF for each replicate, and then the standard deviation for each of 
the PMFs was calculated [Figures 9-11]. 
 
2.6 Small Angle X-Ray Scattering 
 
Small Angle X-Ray Scattering (SAXS) is a powerful technique for determining size and 
shape distributions of proteins and other biological macromolecules in solution (Hayden 
et al 2010). SAXS is useful for working with proteins that may not crystallize, that have 
more than one biologically relevant conformation, and those with large regions of 
intrinsically disordered amino acids. SAXS works with proteins ranging from the small, 
kilodaltons, to gigantic gigadalton complexes (Hayden et al. 2010).  
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SAXS experiments start from a similar place as a crystallography experiment, 
with a highly collimated beam of X-rays or neutrons. These waves interact with atoms in 
the protein to generate secondary wavelets, and these wavelets then either 
constructively or destructively interfere, creating a scattering pattern [Figure 12] 
(Jacques et al. 2010). X-ray crystallography looks at the scattering pattern generated by 
individual atoms in a protein within an ordered crystal lattice, while SAXS looks at the 
scattering profile generated by the collective atoms within a single protein in solution. 
The limiting factor for resolution within these SAXS experiments is the rotational 
averaging of the molecules in solution, with the smallest angle that can be measured 
determining the greatest distance that can be characterized (Jacques et al. 2010). The 
scattering intensity is reported as a function of the amplitude of the scattering vector :  
                                                    =  sin �λ     (8) 
where  is the wavelength of the incident radiation, and θ is half the angle between the 
incident and scattered radiation elements, weighted by their scattering densities. This 
parameter gives information about the shape and density of the protein. One other use 
of the scattering profile is the generation of a Kratky plot which is a plot of �  x  vs  
(Kikhney et al. 2015). This division removes the decay portion of the scattering, and 
allows one to distinguish between disordered and globular proteins. A bell shaped 
Kratky plot is indicative of a well folded globular protein, as the I( ) value for solid 
bodies decays as s approaches values of � /  (Kikhney et al. 2015). Kratky plots 
with plateaus for large values of  are characteristic of unfolded proteins. If the plateau 
is only for a defined range of , then the protein is partially unfolded, while a Kratky plot 
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that extends its plateau for all high values of s represents a completely unfolded protein 
(Kikhney et al. 2015).  
All of these techniques represent quick information that can readily be extracted 
from a few quick transformations of an experimental scattering profile. Further 
information about the shape and organization of a protein requires more 
computationally advanced techniques, such as the DAMMIN technique, developed by 
D.I. Svergun (Svergun 1999). This technique uses a combination of Monte Carlo 
algorithms and the generation of theoretical SAXS curves to evaluate a series of models 
and find those that best match the experimental curve (Svergun 1999). The DAMMIN 
technique begins with a search volume of roughly the maximum particle size, and fills it 
with dummy atoms with a radius much smaller than this maximum search size (Franke 
et al. 2009). These dummy atoms are assigned to either solvent or object, forming the 
DAM or Dummy Atom Model [Figure 2] (Franke et al. 2009).  This dummy atom model 
can be described as a configuration vector with length N, with N being proportional to ��/� . The scattering intensities of the vector can be computed as: 
                                          � = ∑ ∑ |� |= ∞=    (9) 
Where A(s) is:                                                 � = √ / � ∑ ( � ) ∗=� =    (10) 
 
Where r is the polar coordinates, �  is the displaced volume per dummy atom, ∗  are 
the spherical harmonics, and ( � ) is the spherical Bessel function (Franke et al. 
2009). Having a calculated a theoretical scattering profile, we can begin to make 
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changes to bring it in line with an experimental profile. DAMMIN uses a simulated 
annealing algorithm to minimize the function f(X): 
 
   � = � �, � +  ∑ � � �  (11) 
 
Where � �, �  is the discrepancy between the experimental and theoretical scattering 
curves, and ∑ � � �  is the sum of the various penalties designed to keep the DAM 
connected, compact, and close to the origin. The minimization is then done as follows 
(Franke et al. 2009): 
1. Begin with a random DAM X  at high temperature �  
2. Change one atom from either solvent to object, or vice versa, to obtain �′ [Figure 
13]. 
3. Compute  ∆ = �′ − �  
4. If Δ < 0, move to X’, if not move to X’ with a probability of −∆/ �. Move back to 
step 2 with either X’ or X, depending on which was accepted. 
5. Repeat, slowly reducing T until a certain number of total changes have occurred, 
or a certain number of successful changes have occurred.  
 
Since there are likely multiple DAMs that closely match the experimental scattering 
curve, this process will likely result in multiple possible DAMs, which can be averaged to 
get a consensus shape. 
 




The goal of using small angle X-ray scattering (SAXS) in our GluR0 project is to 
compare the predicted ensemble of conformations from our PMFs with experimental 
results obtained through SAXS. We begin by isolating a series of structures pulled from 
snapshots of our MD trajectories. These structures are stripped of waters, ions, etc. and 
have their �  and �  values measured. Those coordinates are saved as PDBs and then 
run through FOXS (Schneidman-Duhovny et al 2013, Schneidman-Duhovny et al 2016), 
a program that generates theoretical SAXS curve for a given profile. Because we know 
the �  and �  values for each of the structures used, and we know the energetics 
associated with those values, we can Boltzmann weight each of those SAXS curves to 
give an ensemble curve that should match experiment.  
SAXS was performed on GluR0 S1S2 LBD obtained from the Mayer lab at the 
NIH, contained within a PETGq vector (Mayer et al. 2001). Protein was expressed in 
Rosetta BL21 E. coli. Cultures were grown overnight in 100 mL Luria-Bertani broth (LB) 
and then diluted 1:40 in 6 L of Terrific Broth (TB). These flasks were then shaken at 37 
C to an absorbance of 0.8 and then induced by the addition of .25 mM IPTG. The 
cultures were then allowed to shake overnight at 16 C and spun down in a Sorvall RC-
3B centrifuge with a GSA rotor at 5000 RPM. Cell pellets were then frozen and stored a 
-80 C. For purification, pellets were resuspended in a solution of 10 mM HEPES pH 7.4, 
50 g/ml DNaseI, and 1 mM PMSF. Resuspended cells were then run through a 
microfluidizer, and then spun down in a Sorvall RCSC centrifuge, in a SS-34 rotor. The 
lysate was spun down for 45 minutes at 4 C and a speed of 16000 RPM. The soluble 
fraction was then incubated with Roche cOmplete His-Tag resin. The slurry was then 
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put into a benchtop gravity column, and washed with 8 column volumes of 10 mM 
HEPES pH 7.4, 150 mM NaCl. After washing the column was then eluted with 10 mM 
HEPES pH 7.4, 150 mM NaCl, and 500 mM Imidazole [Figure 14]. Eluted sample was 
then dialyzed overnight at 4 C in a 10 kDA Molecular Weight Cutoff (MWCO) Snakeskin 
dialysis tubing against a trypsinolysis buffer of 10 mM HEPES pH 7.4, 200 mM NaCl, 
1mM EDTA, 1mM CaCl2. Trypsin lysis was then performed at room temperature for 45 
minutes, using a ratio of 1:100 for trypsin to GluR0. Lysis was stopped by the addition of 
20mM EDTA and 2mM PMSF. Sample was then dialyzed in 25 kDA MWCO snakeskin 
overnight against 10 mM HEPES ph 7.4 25mM NaCl, and 1mM EDTA. Further 
purification was achieved by then running sample over Q-Sepharose anion exchange 
column [Figure 15]. Sample was then finally dialyzed into 10 mM HEPES ph 7.4, 150 
mM NaCl. All purification was done in the presence of 1 mM glutamate or serine. Apo 
protein was obtained by adding 5% w/v glycerol to all buffers and repeatedly dialyzing 
away ligand. SAXS experiments were performed both at the home Hopkins source, a 
Rigaku BioSAXS-2000, and at the SIBLYS beamline in Berkeley. 
 
2.8 SAXS Results 
 
Our goals in using SAXS are to compare the theoretical SAXS curves generated from 
our PMFs with those observed experimentally. Our first task is to observe if the open 
and closed states are distinguishable through SAXS. Our results are shown in figure 16. 
We can clearly distinguish both states, and see that our Boltzmann weighted sample 
falls somewhere between them.  
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 Next we move on to comparing our Boltzmann weighted curves with actual 
experimental results. Our initial results were generated through the SIBLYS mail-in 
SAXS service, with our protein flash frozen in liquid nitrogen, then packed in dry ice and 
shipped to Berkley. These results can be seen in 17. We can easily see that there is a 
gulf between our predicted curves and the actual ones. We checked for evidence of 
aggregation or unfolded protein in our results, which may have thrown off the SAXS 
curves. For aggregation we looked at the Guinier region for our samples, but found no 
evidence for the formation of aggregates [Figure 18]. We looked at Kratky plots for the 
GluR0 LBD, and found sharp, well folded proteins [Figure 19]. Searching for further 
sources of error, we added an extra filtration step to our protein prep, running the GluR0 
through a size exclusion column to filter out any possible contaminants [Figure 20]. 
None of this managed to change our SAXS profiles or reveal any possible source of our 
error. We then began to think that it was the process of freezing and shipping our 
protein to SIBLYS that was throwing off our measurements. To correct for this, we used 
the Rigaku BioSAXS-2000, available at Hopkins, to analyze our GluR0 without needing 
to freeze it in liquid nitrogen. Results from the home source are shown [Figures 21 and 
22]. Switching to the home source did not improve the agreement between our curves, 
so we began to look for other ways to explain the discrepancy. We noticed that our 
experimental radius of gyration calculations where much bigger for our experiment than 
for our theoretical curves, ~18 Å for the FOXS curves versus ~27 Å for our experiment. 
We found that by adding hydration layers and increasing the excluded volume we were 
able to bring the results closer together.  GluR0 has a dimerization dissociation constant 
of 0.8 M, much stronger than the millimolar dissociation constant associated with the 
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AMPA receptor (Chen et al. 1999, Ptak et al. 2014). Wondering if the presence of dimer 
in solution could have thrown off our SAXS curves, we generated a dummy atom model 
(DAM) using the curves from our home source. We used the DAMMIF algorithm, 
generating 13 different models, the average of which is shown in figure 23. The 
resulting model is quite spacious, and much more easily accommodates the dimer 
GluR0 structure, rather than the monomer. We believe that it is this dimer presence in 




























Fig. 1. Depiction of Energy Landscape 
 
In unbiased molecular simulations, one or more large free energy barriers along an 






























Fig 2. GluR0 LBD with Umbrella Sampling Restraints 
 
GluR0 LBD, with highlighted residues showing �  and � . �  includes the 54th and 55th 
residues and the 124th, 125th, and 126th and is shown in orange. �  includes the 13th, 

















Fig 3. GluR0 apo PMF 
PMF for the apo state of the GluR0 ligand binding domain. Contour lines correspond to 
a difference of 1 kcal/mol, with cooler colors being lower in free energy (see color bar). 
Crystal structure �  and � , at 7.7 Å and 10.1 Å, shown as green dot. Crystal structure 







Fig 4. GluR0 Glutamate Bound PMF 
 
PMF for the glutamate bound state of the GluR0 ligand binding domain. Contour lines 
correspond to a difference of 1 kcal/mol, with cooler colors being lower in free energy 
(see color bar). Crystal structure �  and � , at 7.5 Å and 9.9 Å, shown as green dot. 








Fig 5. GluR0 Serine Bound PMF 
 
PMF for the serine bound state of the GluR0 ligand binding domain. Contour lines 
correspond to a difference of 1 kcal/mol, with cooler colors being lower in free energy 
(see color bar). Crystal structure �  and � , at 7.6 Å and 9.9 Å, shown as green dot. 










Fig. 6. GluR0 Principal Components – Apo 
 
Depiction of principal components for the GluR0 LBD in the apo form. Blue and orange 
structures represent the maxima of the motion, with the red arrow showing the axis of 
rotation. The first principal component is a hinge-bending motion, PC2 is a rocking 

































Fig. 7. GluR0 Principal Components – Glu 
 
Depiction of principal components for the GluR0 LBD in the glutamate bound form. Blue 
and orange structures represent the maxima of the motion, with the red arrow showing 
the axis of rotation. The first principal component is a rocking motion, not the hinge-
bending observed in the apo form. Hinge-bending is moved to the second PC, with twist 





















Fig 8.  GluR0 Principal Components – Ser 
 
Depiction of principal components for the GluR0 LBD in the serine bound form. Blue 
and orange structures represent the maxima of the motion, with the red arrow showing 
the axis of rotation. The first principal component is hinge-bending. Rock is the second, 




























Fig. 9. PMF Standard Deviation – GluR0 Apo 
 
Standard deviations are shown in kcal/mol (see the color bar), as determined by block 



















Fig. 10. PMF Standard Deviation – GluR0 Glutamate Bound 
 
Standard deviations are shown in kcal/mol (see the color bar), as determined by block 


















Fig. 11. PMF Standard Deviation – GluR0 Serine Bound 
 
Standard deviations are shown in kcal/mol (see the color bar), as determined by block 

















Fig. 14. His-tag purification of GluR0 LBD 
 






























Fig. 15. Q-Column purification of GluR0 LBD 
 
































Fig. 16. Open and Closed SAXS curves for GluR0  
 
FOXS generated curves for GluR0 in an open (� , � ) = (13, 14 Å) and closed (� , � ) = 
(7, 8 Å) state. In addition, the Boltzmann weighted average curve for GluR0 in the 

















Fig. 17. Theoretical and Experimental SAXS curves for GluR0 
 
SAXS curves taken at the SIBLYS beamline in Berkeley in black, with the 
corresponding theoretical FOXS curve in red. Apo, glutamate bound, and serine bound 







Fig. 18 Guinier Plots For GluR0 from SIBLYS 
Guinier plots for GluR0 ligand binding domain from the SIBLYS beamline at Berkeley. 







Fig. 19 Kratky Plots For GluR0 from SIBLYS 
Kratky plots for GluR0 ligand binding domain from the SIBLYS beamline at Berkeley. All 








Fig. 20. GluR0 LBD S200 Purification 
 

























Fig. 21. Kratky Plots For GluR0 from Rigaku 
 
Kratky and Guinier plots for serine bound GluR0 taken from the home source Rigaku. 
The Kratky plot shows one peak, indicative of a well folded protein, and the Guinier 



























Fig 22. Theoretical and Experimental SAXS curves for GluR0 – Rigaku 
 
SAXS curves taken of the serine bound GluR0 LBD at the Rigaku machine at Hopkins, 













Fig. 23. Image of SAXS envelope and GluR0 dimer 
 
Dummy Atom Model generated through the use of serine bound GluR0 scattering 
curves obtained off of the home source Rigaku. This is the model generated from 



























 PC1 PC2 PC3 
GluR0 - Apo 68.4 % 17.1 % 6.8 % 
GluR0 – Glu 38.2 % 22.3 % 11.7 % 
GluR0 - Serine 41.6 % 20.3 % 11.0 % 
 




Chapter 3: Experimental Characterization of GluA2 Dimer Constructs 
 
Desensitization is the process by which an active iGluR, one that has bound its 
corresponding agonist, closes its transmembrane domain. This closure occurs even 
though the agonist remains bound in the ligand binding domain [Figure 1].  
Previous studies in the Lau lab have looked at the energetics of the AMPA receptor 
dimer [Figure 2]. In addition to this computational work, SAXS experiments were 
performed by Sara Bastos to verify that the ensemble measurements of the SAXS 
matched those predicted by the dimer PMFs (Unpublished Data). To further observe the 
behavior of the AMPA dimers and their various mutants, analytical ultracentrifugation 





Glutamate receptor activation occurs when a ligand binds into a ligand binding domain, 
inducing domain closure. This closure puts strain on the flexible linker regions 
surrounding the LBD, which is then relieved due to structural rearrangements in the 
transmembrane domain and the amino terminal domain (Chaudry et al. 2009, Weston et 
al. 2006). In the transmembrane domain, these rearrangements lead to pore opening, 
and thus depolarization. Desensitization occurs when the transmembrane domain 
closes, even though the ligand binding domain is still occupied by an agonist (Meyerson 
et al 2014). Both of these processes, activation and desensitization, occur on a 
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millisecond long time scale (Weston et al. 2006). Desensitization allows the both the 
tuning of responses to high frequency synaptic activity, and prevents cell damage from 
occurring due to excitotoxicity (Weston et al 2006). This occurs through a 
rearrangement of the ligand binding domains that relieve stress on the linker regions 
while still maintaining a closed conformation (Meyerson et al. 2014, Weston et al. 2006). 
It is this rearrangement that is the central question of desensitization.  
 
3.2 Analytical Ultracentrifugation Theory 
 
Analytical Ultracentrifugation is a powerful method for studying the shape and 
stoichiometry of proteins and protein complexes. AUC works over a variety of 
concentration ranges, in a wide variety of solvent conditions, and works non-
destructively to allow recovery of precious samples after an experiment is completed 
(Lebowitz et al. 2002). There are two complementary techniques within AUC: 
sedimentation velocity (SV) and sedimentation equilibrium (SE). SE provides 
thermodynamic information about properties such as stoichiometry and association 
constants. SV, which will be the focus of this thesis, provides hydrodynamic information 
about particle properties such as shape and size (Howlett et al, 2006). 
 Both the SE and SV experiments start from similar places, with an AUC cell 
containing both sample and blank spun in a rotor at high speed, anywhere from 10000 
to 60000 RPM (Cole et al, 1999). At various times in this experiment, on the order of 
seconds to minutes for SV and hours to days for SE, the concentration of protein along 
the column is taken using either interference or absorbance optics. It is this 
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measurement that is the fundamental data point of AUC, with SV experiments 
concerned with the travel of protein down the column as the experiment progresses, 
and SE experiments concerned with the equilibrium position of the distribution. 
 There are two important equations for AUC: the Svedberg equation and the 
Lamm equation. 
The Svedberg equation is: ��� −�� =        (1) 
Where R is the gas constant, T is the temperature, s is the sedimentation coeffecient, D 
is the diffusion constant, � is the volume of displaced fluid, � is the density of the 
solvent, and M is the mass of particle. The above equation allows us to derive unknown 
qualities of the particle under experiment, such as the diffusion or frictional coefficients, 
from known quantities such as mass, and the experimental observation s. 
 Having shown the utility of the experimental quantity s, we must then answer how 
does one measure that quantity from a SV experiment? While there are a number of 
methods for deriving this, both historical and contemporary, all start with the Lamm 
equation (Schuck et al. 2003): 
∂�∂ = ∂∂ [ � ∂�∂ −  χsr ω  ]      (2) 
With the � ∂�∂  representing flux from diffusion, χsr ω  term representing flux due to 
sedimentation, and χ representing the local concentration of the particle of interest. 
Solving this equation for s is complicated, and for the purposes of this thesis, we will 
turn to the c(s) method. This is implemented in the program SEDFIT, developed by 
Peter Schuck at the NIH. This is a numerical solution to the Lamm equation, shown by: , =  ∫ , , , �  (3) 
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With ,  representing experimental data,  representing the concentration of 
sedimentation coefficients between s and s+ds, and , , , �  representing the Lamm 
equation. The c(s) method works by generating several theoretical sedimentation 
profiles for various values of s, and then adjusts their concentration in the ensemble in 




Sedimentation velocity experiments were performed on two different GluA2 dimer 
constructs, a Leucine-483 to tyrosine (L483Y) mutant known to promote stabilization of 
the dimer (Hansen et al, 2007), and a triple mutant of Leucine-483 to alanine, Leucine-
748 to alanine, and Lysine-752 to alanine, (3M) designed to destabilize the dimer 
(Horning et al 2004). All constructs were designed with a seven amino acid extension of 
the C-Terminus: GGGASCS. This linker was designed to promote dimer formation in 
the constructs by allowing the cysteine to form a disulfide bond, linking two LBDs 
together.  
All constructs were expressed in PET vectors and grown in Rosetta E. Coli. 
Cultures were grown overnight in 100mL Luria Broth (LB) and then diluted 1:40 in 6 L of 
Terrific Broth (TB). These flasks were then shaken at 37°C to an absorbance of 0.8 and 
then induced with .25 mM of IPTG. The cultures were then allowed to shake overnight 
at 16°C and spun down in a Sorvall RC-3B centrifuge with a GSA rotor. Cell pellets 
were then frozen and stored a -80°C. 
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For purification, pellets would be resuspended in a solution of 20 mM TRIS pH 
8.0, 150 mM NaCl, 5mM Methionine, 1mM Glutamate, 5 mM MgSO4, 1mM PMSF, and 
25 μg/mL of DNAse1. Resuspended cells were then lysed with a microfluidizer, and 
then spun down in a Sorvall RCSC centrifuge, in a SS-34 rotor at 16000 RPM. The 
lysate was then spun down for 45 minutes at 4°C. The soluble fraction was then 
incubated with Roche cOmplete His-Tag resin [Figures 3 and 5]. The slurry was poured 
into a benchtop gravity column, and washed with 8 column volumes of 20 mM TRIS pH 
8.0, 150 mM NaCl, 5mM Methionine, and 1mM Glutamate. After washing, the protein 
was then eluted with 20 mM TRIS pH 8.0, 150 mM NaCl, 5mM Methionine, 1mM 
Glutamate, and 500 mM Imidazole. Eluted sample was then dialyzed overnight at 4°C in 
a 10 kDA (Molecular Weight Cut Off) MWCO Snakeskin dialysis tubing against a 
trypsinolysis buffer of 20 mM TRIS pH 7.4, 200 mM NaCl, 1mM Glutamate, 5mM 
Methionine, 1mM EDTA, 1mM CaCl2. Trypsin lysis was then performed at room 
temperature for 45 minutes, using a ratio of 1:100 for trypsin to GluA2. Lysis was 
stopped by the addition of 20mM EDTA and 2mM PMSF. Sample was then dialyzed in 
25 kDA MWCO snakeskin overnight against 20 mM HEPES ph 7.0 20mM NaCl, 10 mM 
glutamate, 1mM EDTA. Sample was concentrated and run over a S200 gel filtration 
column [Figures 4 and 6]. Peak fractions were pooled and dialyzed in 25 kDA MWCO 
snakeskin overnight against 20 mM HEPES ph 7.0 140mM NaCl 10mM Glutamate 1mM 
EDTA. 
Sedimentation velocity (SV) experiments were performed on a Beckman XL-I 
centrifuge at a speed of 42000 RPM, in an AN60Ti rotor. All runs were done at 4 C, and 
collected using absorbance optics at 280 nM with 0.001 cm radial steps.in a buffer of 20 
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mM HEPES ph 7.0 140mM NaCl 10mM Glutamate 1mM EDTA. All SV was done at a 
concentration of ~0.8 mg/mL. All runs were analyzed in SEDFIT (Schuck 2000) and 




The Lamm equation reads as:    
                                               
∂�∂ = ∂∂ [ � ∂�∂ −  χsr ω  ]        (4) 
One of the fitting parameters for the Lamm equation is D, the diffusion coefficient. D is 
itself dependent on f/f0 as shown: 
� , ��0 =  √8� ��√  η ��0 − /  √ −vpv         (5) 
f/f0 is a representation of the proteins deviation from an ideal spherical shape (Smith et al 
2008). The f/f0 scale begins at 1, for an ideal sphere. Most globular proteins will have a 
value of 1.05 to 1.3, and as f/f0 increases the shape becomes more and more oblong 
[Figure 7]. As we perform c(s) analysis on our AUC runs, we fit for both the 
sedimentation coefficient and for the ensemble average f/f0 value. We expect that as we 
fit f/f0 for both the L483Y and the 3M mutants of our GluA2 LBD, we will see a higher 
value for the 3M mutant than the L483Y, reflecting the destabilization of the dimer 
interface. Our plots for the c(s) fits is shown in figures 8-11. The table of values is 
shown in table 1.  
We see sharp and distinct peaks for both of our mutants. This allows us to be 
fairly certain that the cysteine linkers are working, otherwise we would see a mixture of 
dimer and monomer peaks. Even in the absence of a cysteine linker, the L483Y mutant 
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should show a significant dimer signal, given the nanomolar affinity the mutation gives 
to the ligand binding domain. There is some evidence for higher order oligomers, 
especially in the L483Y run. Further experiments are needed verify that we are 
measuring the dimer state of GluA2 in our AUC. Running the same experiment in the 
presence of reducing agent should confirm this. For the L483Y we should see similar 
results, while the triple mutant should show a lower sedimentation coefficient without the 
cysteine linkers to hold them together.  
Overall, we see evidence that the 3M mutant is showing a higher f/f0, reflecting an 
elongated shape relative the L438Y mutant, although each is within the error range of 
the other. More accurate f/f0 values are only going to be accessible through performing 
global fits on both S and f/f0. This will require performing more runs at a variety of 
speeds and concentrations. Even then, while we may be able to differentiate between 
both of the GluA2 mutants and the wild type dimer, the basic f/f0 measurement may not 
be able to reveal the structural changes these dimers undergo. A more detailed view of 
the dimer interactions may require synthesizing results from multiple shape determining 













Fig 1. Model of Desensitization (Courtesy Albert Lau) 
Activation and desensitization of glutamate receptors works as a three step process. 
Glutamate binds into apo ligand binding domain, inducing hinge closure. This closure 
then opens the transmembrane domain. Finally, the LBDs reorient themselves to allow 


















Fig 2. GluA2 Dimer PMF 
Structural energetics associated with various LBD orientations. Individual ligand binding 
domains are colored wheat and blue, and residues known to be important in dimer 








Figure 3 GluA2 L483Y 
 
 
Fig 3. GluA2 L483Y His-tag Purification 
GluA2 L483Y purified from Rosetta E. coli. Washes 1-4 took place in 20 mM TRIS pH 
8.0, 150 mM NaCl, 5mM Methionine, and 1mM Glutamate. Elutions used 20 mM TRIS 
pH 8.0, 150 mM NaCl, 5mM Methionine, 1mM Glutamate, and 500 mM Imidazole. 
GluA2 L483Y came off clean and without any noticeable contamination. Lane 10 is the 










Fig 4. GluA2 L483Y Size Exclusion Purification 
GluA2 L483Y was run through an S200 and eluted in 20 mM HEPES ph 7.0 20mM 













Fig 5. GluA2 Triple Mutant His-Tag Purification 
GluA2 triple mutant purified from Rosetta E. coli. Washes 1-4 took place in 20 mM TRIS 
pH 8.0, 150 mM NaCl, 5mM Methionine, and 1mM Glutamate. Elutions used 20 mM 
TRIS pH 8.0, 150 mM NaCl, 5mM Methionine, 1mM Glutamate, and 500 mM Imidazole. 









Fig 6. GluA2 Triple Mutant Size Exclusion Purification 
GluA2 triple mutant was run through an S200 and eluted in 20 mM HEPES ph 7.0 
20mM NaCl, 10 mM glutamate, 1mM EDTA. GluA2 triple mutant showed some bands at 













Figure 8: GluA2 L483Y c(s) 
 
 
Fig 8. c(s) graph for GluA2 L483Y mutant 
Main peak is at 2.7 S, with a smaller peak at 3.9 S. Main peak should be dimer, with the 










Figure 9: GluA2 L483Y c(s) fit and residuals 
 
Fig 9. Fit and residuals for L483Y mutant c(s) analysis 
Top graph shows fit between experimental and c(s) data, with each scan color coded. 









Fig 10. c(s) graph for GluA2 Triple mutant 
Main peak is at 2.7 S. Some signal in the higher S region, but less so than in the L483Y 
mutant. The higher dimer affinity of the L483Y mutant may explain the sharp distinct 









Figure 11: GluA2 3M c(s) fit and residuals 
 
Fig 11. Fit and residuals for Triple mutant c(s) analysis 
Top graph shows fit between experimental and c(s) data, with each scan color coded. 









Table 1: f/f0 Values for GluA2 dimer constructs 
 
L483Y 3M 

















Chapter 4: Principal Component Analysis of GluN Ligand Binding 
Domains 
Reproduced in part from: 
Conformational Analysis of NMDA Receptor GluN1, GluN2, and GluN3 Ligand-Binding 
Domains Reveals Subtype-Specific Characteristics, Structure vol.21 issue 10 8 October 
2013 
by 
Yongneng Yao, John Belcher, Anthony J. Berger, Mark L. Mayer, and Albert Y. Lau 
 
4.1 GluN Ligand Binding Domain Simulations 
 
The NMDA receptor family of glutamate receptor ion channels is formed by obligate 
heteromeric assemblies of GluN1, GluN2, and GluN3 subunits. GluN1 and GluN3 bind 
glycine, whereas GluN2 binds glutamate. Dr. Albert Lau performed umbrella sampling 
simulations yielding the PMFs in Figures 1-3.  
 
4.2 Bootstrapping of GluN Ligand Binding Domain Simulations  
 
The range of variation in each PMF was estimated using a bootstrapping approach 
(Wehrens et al 2000). �  and �  for each GluN umbrella window was resampled using a 
window of 300 ps. On average, correlated fluctuations in  �  and �   decay reasonably 
close to zero within these windows, as assessed from a calculation of the 
autocorrelation function (Box et al, 2008): 
� =  ∑ ��− �̅ ��+�− �̅�−��= ∑ ��− �̅��=  (1) 
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Where N is the total number of time steps, k is the number of time steps corresponding 
to a given lag time, x is either  �  or � , and the overbar indicates an average.  
The error range for these plots are shown in figures 1-3. 
 
4.3 Principal Component Analysis Methods 
 
Hinge-bending motions are the dominant large-scale structural variations observed in 
crystallographic analyses of GluR LBDs when agonist complexes are compared with the 
apo state or antagonist complexes (Bjerrum and Biggin, 2008; Mayer, 2011; Pøhlsgaard 
et al., 2011; Stawski et al., 2010). These motions are highly correlated with the order 
parameter (� ,� ). Additional modes of interlobe motions orthogonal to (� ,� ), however, 
may also contribute to the conformational dynamics of receptor activation (Birdsey-
Benson et al., 2010). Such secondary modes are difficult to distinguish from hinge 
bending using only (� ,� ) as an indicator. In principle, additional order parameters could 
be used to differentiate among the various conformational modes, but incorporating 
them into an umbrella sampling strategy would require substantially more computational 
time because sampling scales exponentially with the number of order parameters. We 
thus sought to characterize LBD motions using principal component analysis (PCA), 
which can determine the large-scale characteristic motions of a protein from an 
ensemble of protein configurations (García, 1992; Grossfield and Zuckerman, 2009; 
Levy et al., 1984). 
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PCA calculations involve the diagonalization of the covariance matrix Cij of 
positional deviations among an ensemble of protein structures (Grossfield and 
Zuckerman, 2009; Levy et al., 1984):  � =  ���(� , � ) = �[ � −  μ (� − μ )] (2) 
Where �  represents a specific Cα coordinate, � is an operator that denotes the mean 
of its argument, and μ  is the average positional value for the i-th Cα. The eigenvectors, 
or principal components (PCs), represent the characteristic motions observed in the 
ensemble, and each eigenvalue is the mean square fluctuation associated with the 
corresponding eigenvector. The ensemble, generated separately for each iGluR LBD in 
either the apo- or glycine/glutamate-bound state, consists of protein conformers from all 
umbrella sampling windows in which W(� ,� ) is less than 2 kcal/mol. This subset 
includes the vast majority of conformations that are expected to be observed in a 
Boltzmann-weighted ensemble while excluding conformations that are energetically 
difficult to access. This is a cruder calculation than the one presented in chapter 2. Here 
every conformation is weighted equally, in contrast to the Boltzmann weighting shown 
earlier. PCs were also computed using cutoffs of 1 and 3 kcal/mol, and the results were 
similar. Only Cα coordinates were used in the calculations. All conformers were first 
superimposed onto lobe 1 of a reference structure using a selection of Cα atoms that 
excludes flexible loops. The references for GluN1, GluN2A and GluN3A are PDB ID 
codes 4KCC, 2A5S, 4KCD(A), respectively. Next, the lobe 1 Cα atoms of the reference 
structure were joined to the lobe 2 Cα atoms of each simulated conformer to construct 
an ensemble of pseudo-rigid-body structures. The ensembles for apo- and glycine-
bound GluN1 include 22,262 and 7,007 conformers, respectively. The ensembles for 
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apo- and glutamate-bound GluN2A include 12,685 and 7,436 conformers. The 
ensembles for apo- and glycine-bound GluN3A include 11,917 and 4,709 conformers. 
PCA calculations were performed using Bio3D (Grant et al., 2006). The axes of rotation 
characterizing PC1–PC3 were calculated using the DomainSelect method provided by 
the DynDom server (Hayward and Berendsen, 1998). Endpoint coordinates were 
generated using Bio3D. Lobe 1 is the ‘‘fixed’’ domain, and lobe 2 is the ‘‘moving’’ 
domain. For GluN1, lobe 1 is defined as residues 399–534 and 758–786, and lobe 2 is 
defined as residues 537–754. For GluN2A, lobe 1 is defined as residues 407–529 and 
761–789, and lobe 2 is defined as residues 532–757. For GluN3A, lobe 1 is defined as 
residues 515–649 and 873–901, and lobe 2 is defined as residues 652–869.  
 
4.4 Principal Component Analysis Results 
 
The dominant three PCs that characterize interlobe conformational transitions are 
described for each of the LBDs (Figures 4-6; Table 1). For the apo LBDs, PC1 
corresponds, as expected, to a hinge-bending motion (Figures 4A, 5C, 6A) and 
accounts for the majority of the proportion of variance in large-scale transitions, with 
additional eigenvectors accounting for increasingly smaller contributions (Table 1). PC2 
corresponds to a sweeping motion for the apo GluN1 and GluN3A LBDs but a rocking 
motion for the apo GluN2A LBD (Figures 4B, 5D, 6B). PC3 corresponds to a twisting 
motion for the apo LBDs (Figures 4C, 5C, 6C). The difference between the sweeping 
and twisting motions is that the sweeping rotational axis falls ‘‘behind’’ lobe 2, whereas 
the twisting axis penetrates lobe 2. The first two eigenvectors have previously been 
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computed for the apo GluN1 LBD (Kaye et al., 2006), and they are similar to the PCs 
described here. 
Upon glycine or glutamate binding to the LBD, PC1 retains a hinge-bending 
motion for all LBDs except GluN3A, which converts to a rocking motion (Figures 4A, 5A, 
6A). Upon glycine binding, PC2 converts from a sweeping to a rocking motion for GluN1 
and from a sweeping to a hinge-bending motion for GluN3A (Figures 5D). By contrast, 
upon glutamate binding, PC2 retains rocking and sweeping motions for GluN2A (Figure 
6). PC3 retains a twisting motion for all LBDs upon either glycine or glutamate binding 
(Figures 4-6), although the axis of rotation undergoes a tilt for the glycine-binding LBDs. 
Note that because the PCs were calculated separately for the apo- and glycine/ 
glutamate-bound LBDs, the same eigenvalue does not necessarily correspond to the 
same conformation. The proportion of variance accounted for by each of the different 
PCs is provided in Table 1.  
In comparing the PC motions with (� ,� ), the hingebending motions generally fall 
along a positive-slope diagonal in (� ,� ), whereas the other PCs are described in part 
by configurations off this diagonal. The PMFs indicate that cleft opening appears to be 
skewed to be greater along �  than �  for the three NMDA receptor LBDs compared with 
GluA2. This skew is reflected in the tilt of the rotational axes corresponding to hinge 
bending, which is steeper for the glycine binding subunits.  
 
4.5 Modelling of Principal Components within a GluN2A/GluN1 Tetramer 
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With the availability of a full length crystal structure of a GluN2B/GluN21 crystal 
structure, we can see how motions along the principal components we calculated for 
our LBDs affect their intra-tetramer differences (Lee et al. 2014).   
 The full length NMDA crystal structure consists of GluN1 in chains A and C, and 
GluN2B in chains B and D. For our model we superimposed the maxima and minima of 
our principal components on to the ligand binding domain for one of the appropriate 
chains. For GluN1 we modeled our PCs on chain A, and for GluN2A we superimposed 
our structures onto chain B. For GluN1 the distances were measured from the Cα of the 
155th residue, to the Cα of glycine 728 in chain B, the Cα of glycine 740 in chain C, and 
the Cα of serine 736 in chain B. For GluN2A the distances were measured from the Cα 
atom of the 143rd residue, to the Cα of glycine 740 in chain C, the Cα of glycine 728 in 
chain C, and the Cα of glycine 740 in chain B. Distance was measured between the 
maxima and minima for the principal component and each chain. 
 The first principal component for GluN1, hinge-bending, mainly varies the 
distance between chain A and D, with a much smaller change for both the B and C 
chains [Figure 7]. The second principal component, sweeping, inverts this. PC2 for 
GluN1 in the apo state affects the distance from chain A to chain B or C to a greater 
extent than the A-D distance [Figure 8]. PC3 affects inter-lobe distances equally 
between all three chains and chain A [Figure 9].  
 Upon ligand binding we see the motions are damped in general, with our greatest 
amplitude of motion being 2.1 Å compared to 5.0 Å in the apo form. Glycine bound PC1 
still mostly affects the A-D distance, with smaller contributions to A-C, and A-B [Figure 
10]. PC2, which converts from sweeping in the apo state to rocking here, has a greater 
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effect on the chain A to chain C and chain B distances, rather than the chain A to chain 
D distance [Figure 11]. PC3 has hardly any effect and inter-lobe distances, with its 
greatest amplitude of motion only being 0.5 Å between chain A and chain B [Figure 12]. 
 The principal components of the apo form of GluN2A have a similar effect as the 
principal components of the apo form of GluN1. Hinge-bending primarily effects the B-C 
distance in the tetramer, with smaller contributions to B-D and B-A distances [Figure 
13]. PC2 has almost no effect on B-C distance (-0.6 Å) with a much greater change in 
B-D and B-A distances, -2.5 Å and -2.6 Å respectively [Figure 14]. PC3 contributes little 
in the apo form, with its greatest amplitude being 0.5 Å for the B-C distance [Figure 15]. 
 Glutamate binding has an effect on the magnitude of inter-lobe differences, but 
not on their distribution. Once again PC1 primarily affects B-C distance [Figure 16]. PC2 
has a much greater effect on B-D and B-A distances, and a smaller one on the B-C 
distance [Figure 17]. PC3 once again has little effect on any inter-chain differences, with 




The dominant three principal components for all four LBDs may be classified as hinge 
bending, sweeping, rocking, or twisting motions. For the apo LBDs, PC1 corresponds to 
hinge bending, and PC3 corresponds to twisting. PC2 corresponds to sweeping for all 
apo LBDs except GluN2A, which is rocking. The characteristic motion for PC2 therefore 
does not differentiate between glycine- and glutamate-binding LBDs. Upon glutamate 
binding to GluN2A, the characteristic motions for PC 1–3 remain the same. By contrast, 
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many of these motions change upon glycine binding to GluN1 and GluN3A: sweeping 
converts to rocking for GluN1 (PC2), and for GluN3A, hinge bending goes to rocking 
(PC1), and sweeping to hinge bending (PC2). Additionally, the rotational axis for 
twisting undergoes a tilt (PC3). The different behaviors for the glycine- and glutamate-
binding LBDs may result from the different binding site architectures and mechanics 
required to selectively bind glycine versus glutamate. 
 Looking at how these principal components effect inter-lobe distances, we can 
see that principal component 1, hinge-bending, has a much greater effect of changing 
the distance between the moving domain and one of its neighbors. In the case of the 
chain A GluN1, this neighbor is chain D GluN2B. In the case of GluN2A chain B, this 
neighbor is the chain C GluN1. The fact that the primary motion for both of these LBDs 
has a ‘preferred’ partner may tell us more about what possible interactions may be 
necessary to gate and desensitize these receptors. Looking further ahead, we may wish 
to look for interactions between these LBDs to try and observe possible interactions 














Fig.1. PMFs and Bootstrapping results for GluN1 in the apo and glycine bound 
forms. 
PMF for the apo and glycine bound states of the GluN1 ligand binding domain are 
shown on the left. Contour lines correspond to a difference of 1 kcal/mol, with cooler 
colors being lower in free energy (see color bar). Crystal structures are shown as yellow 
dots along with their corresponding PDBids. On the right is the error range calculated 








Fig.2. PMFs and Bootstrapping results for GluN3A in the apo and glycine bound 
forms. 
PMF for the apo and glycine bound states of the GluN3A ligand binding domain are 
shown on the left. Contour lines correspond to a difference of 1 kcal/mol, with cooler 
colors being lower in free energy (see color bar). Crystal structures are shown as yellow 
dots along with their corresponding PDBids. On the right is the error range calculated 









Fig.3. PMFs and Bootstrapping results for GluN2A in the apo and glutamate 
bound forms. 
PMF for the apo and glutamate bound states of the GluN2A ligand binding domain are 
shown on the left. Contour lines correspond to a difference of 1 kcal/mol, with cooler 
colors being lower in free energy (see color bar). Crystal structures are shown as yellow 
dots along with their corresponding PDBids. On the right is the error range calculated 





Figure 4: GluN1 Apo PCAs 
 
Fig.4. Principal Component Analysis of GluN1 in the apo and glycine bound 
forms. 
Depiction of principal components for the GluN1 LBD in the apo and glycine bound 
forms. Blue and wheat structures represent the maxima of the motion, with the red 















Fig.5. Principal Component Analysis of GluN3A in the apo and glycine bound 
forms. 
Depiction of principal components for the GluN3A LBD in the apo and glycine bound 
forms. Blue and wheat structures represent the maxima of the motion, with the red 











Fig.6. Principal Component Analysis of GluN2A in the apo and glutamate bound 
forms. 
Depiction of principal components for the GluN2A LBD in the apo and glutmate bound 
forms. Blue and wheat structures represent the maxima of the motion, with the red 













Fig.7. Motions along the First Principal Component of GluN1 Apo Modeled on 
Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN1 principal 
component 1, superimposed onto the ligand binding domain of chain A of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 155 in the GluN1 ligand binding domain. In chain D, red dot is the Cα 
of glycine 728. In chain C, red dot is the Cα of glycine 740. In chain B, red dot is the Cα 
of serine 736. Distance was measured between the maxima and minima for the 









Fig.8. Motions along the Second Principal Component of GluN1 Apo Modeled on 
Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN1 principal 
component 2, superimposed onto the ligand binding domain of chain A of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 155 in the GluN1 ligand binding domain. In chain D, red dot is the Cα 
of glycine 728. In chain C, red dot is the Cα of glycine 740. In chain B, red dot is the Cα 
of serine 736. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 






Fig.9. Motions along the Third Principal Component of GluN1 Apo Modeled on 
Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN1 principal 
component 3, superimposed onto the ligand binding domain of chain A of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 155 in the GluN1 ligand binding domain. In chain D, red dot is the Cα 
of glycine 728. In chain C, red dot is the Cα of glycine 740. In chain B, red dot is the Cα 
of serine 736. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.10. Motions along the First Principal Component of GluN1 Glycine Bound 
Modeled on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN1 principal 
component 1, superimposed onto the ligand binding domain of chain A of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 155 in the GluN1 ligand binding domain. In chain D, red dot is the Cα 
of glycine 728. In chain C, red dot is the Cα of glycine 740. In chain B, red dot is the Cα 
of serine 736. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.11. Motions along the Second Principal Component of GluN1 Glycine Bound 
Modeled on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN1 principal 
component 2, superimposed onto the ligand binding domain of chain A of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 155 in the GluN1 ligand binding domain. In chain D, red dot is the Cα 
of glycine 728. In chain C, red dot is the Cα of glycine 740. In chain B, red dot is the Cα 
of serine 736. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.12. Motions along the Third Principal Component of GluN1 Glycine Bound 
Modeled on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN1 principal 
component 3, superimposed onto the ligand binding domain of chain A of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 155 in the GluN1 ligand binding domain. In chain D, red dot is the Cα 
of glycine 728. In chain C, red dot is the Cα of glycine 740. In chain B, red dot is the Cα 
of serine 736. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.13. Motions along the First Principal Component of GluN2A Apo Modeled on 
Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN2A principal 
component 1, superimposed onto the ligand binding domain of chain B of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 143 in the GluN2A ligand binding domain. In chain A, red dot is the Cα 
of glycine 740. In chain C, red dot is the Cα of glycine 740. In chain D, red dot is the Cα 
of glycine 728. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.14. Motions along the Second Principal Component of GluN2A Apo Modeled 
on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN2A principal 
component 2, superimposed onto the ligand binding domain of chain B of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 143 in the GluN2A ligand binding domain. In chain A, red dot is the Cα 
of glycine 740. In chain C, red dot is the Cα of glycine 740. In chain D, red dot is the Cα 
of glycine 728. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 






Fig.15. Motions along the Third Principal Component of GluN2A Apo Modeled on 
Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN2A principal 
component 1, superimposed onto the ligand binding domain of chain B of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 143 in the GluN2A ligand binding domain. In chain A, red dot is the Cα 
of glycine 740. In chain C, red dot is the Cα of glycine 740. In chain D, red dot is the Cα 
of glycine 728. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.16. Motions along the First Principal Component of GluN2A Glutamate Bound 
Modeled on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN2A principal 
component 1, superimposed onto the ligand binding domain of chain B of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 143 in the GluN2A ligand binding domain. In chain A, red dot is the Cα 
of glycine 740. In chain C, red dot is the Cα of glycine 740. In chain D, red dot is the Cα 
of glycine 728. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.17. Motions along the Second Principal Component of GluN2A Glutamate 
Bound Modeled on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN2A principal 
component 2, superimposed onto the ligand binding domain of chain B of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 143 in the GluN2A ligand binding domain. In chain A, red dot is the Cα 
of glycine 740. In chain C, red dot is the Cα of glycine 740. In chain D, red dot is the Cα 
of glycine 728. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







Fig.18. Motions along the Third Principal Component of GluN2A Glutamate Bound 
Modeled on Tetramer Structure 
Maxima and minima, colored wheat and blue respectively, of GluN2A principal 
component 3, superimposed onto the ligand binding domain of chain B of the full length 
NMDA tetramer (PDBid: 4TLL) (Lee et al. 2014). Orange and blue dots are the Cα 
atoms of residue 143 in the GluN2A ligand binding domain. In chain A, red dot is the Cα 
of glycine 740. In chain C, red dot is the Cα of glycine 740. In chain D, red dot is the Cα 
of glycine 728. Distance was measured between the maxima and minima for the 
principal component and each chain. Distance was measured between the maxima and 







 PC1 PC2 PC3 
GluN1 - Apo 69.4 20.1 4.2 
GluN1 – Gly 27.5 21.5 13.3 
GluN2A – Apo 70.8 15.8 4.5 
GluN2A – Glu 53.9 18.1 7.3 
GluN3A – Apo 74.1 13.2 4.2 
GluN3A – Gly 30.3 23.3 9.1 
 









Chapter 5: Future Directions 
5.1 GluR0 Future Directions 
Further work on GluR0 should focus on three things: working on making a SAXS 
measurement of the monomer, observing how glutamate and other agonists bind to the 
ligand binding domain, and looking at how the dimer interface affects the energy 
landscape available  
 Ideally we would measure a monomeric version of the GluR0 LBD to 
complement our experimental work. Currently we believe that the presence of dimer 
within our SAXS measurements is preventing our theoretical results from matching up 
with our experimental ones. There are a few ways to approach this problem. First, we 
could try making measurements at lower concentrations of protein. Our current SAXS 
experiments have a minimum protein concentration of 3 mgs/mL. Lowering that 
concentration could push more of the signal to come from the monomer, although it is 
likely that we would need to return to SIBLYS to measure what may be a low signal. In 
addition to lowering the amount of protein in our SAXS experiments, we can look at 
making mutations that will disrupt the dimer interface. Work has been done on GluR0 
derived from another organism, Nostoc punctiforme, another cyanobacteria (Lee et al. 
2008). It has been found that a one amino acid switch, a glutamate to a lysine, 
completely abolishes dimerization, as observed through analytical ultracentrifugation 
(Lee et al. 2008). This NPGluR0 however, does have a different dimer interface than 
our synechococcus GluR0, with a lower dissociation constant of 15.4 mM as compared 
to our SGluR0 dissociation constant of 0.8 μM (Lee et al. 2008). Despite their 
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differences, we may be able to use the NPGluR0 dimer interface as a model to mutate 
our SGluR0 into a form that does not strongly dimerize in solution. 
 Another interesting question to consider with regards to the GluR0 LBD, is how it 
acts in a dimer. Because this prokaryotic glutamate receptor lacks the amino terminal 
domain of its eukaryotic counterparts, much of the assembly of the extracellular domain 
is left to the LBDs themselves. In addition to lacking the aid of the amino terminal 
domain in assembling the receptor, the dimer interface of GluR0 is believed to only 
involve amino acids on the upper lobe (Mayer et al. 2001). Looking at how our PMFs 
change in the presence of the GluR0 dimer would be instructive on explaining some of 
the behavior of GluR0 electrophysiology experiments. While we observe a flexible LBD 
that can access both open and closed states, the dimer interface may prevent the apo 
form from accessing either. Similar arguments can be made for the glutamate and 
serine bound forms. Ultimately, in looking only at the monomer, we are looking at the 
GluR0 LBD in its simplest state. Understanding how these receptors work requires 
looking at them in their physiological state, and for GluR0 that means scaling up the 
monomer simulation into a dimer.  
A final question is how glutamate binds into the GluR0 ligand binding domain. 
Previous studies done in the lab (Yu and Lau 2017) have shown how binding of the 
ligand to the LBD can be guided by residues outside of the binding pocket. Using both 
the string method (Meng et al. 2016) and large scale simulations such as those on 
ANTON, we can see if the prokaryotic glutamate receptor uses a similar binding path, or 
if there are multiple ways to steer glutamate into the binding pocket. Comparing the 
glutamate binding pathway with the serine binding pathway would allow us to see if 
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GluR0 binding partners share binding pathway, or if binding multiple ligands means 
there are multiple paths to the bound state.  
 
5.2 GluA2 Future Directions 
 
Future work on GluA2 needs to do three things: verify that our AUC measurements are 
being done on the dimer state of GluA2 in both mutants, derive more accurate frictional 
ratios by performing global fits on the AUC data, and use the AUC data to construct 
more accurate shape models for our GluA2 mutants. 
 The first step is to verify that our AUC results are for the GluA2 dimer. As 
described in chapter 3, performing the same experiments in the presence of reducing 
agents should eliminate the disulfide bonds holding our LBDs together. We expect that 
we would then see a more slowly sedimenting species appear in our AUC runs, 
corresponding to a higher presence of GluA2 monomer. This difference should be much 
more noticeable in the triple mutant than in the L483Y, with its lower affinity for 
dimerization. 
Frictional ratios cannot be accurately calculated from only one sedimentation 
velocity experiment (Brown and Schuck 2006). Global fits of f/f0 are necessary in order 
to improve the resolution of our frictional ratio values. More sedimentation velocity 
experiments, ones in which the concentration of protein and the speed of the rotor are 
varied, are needed. These global fits should improve the resolution of our f/f0, and 
enable us to differentiate between the two mutants and the wild type GluA2. 
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Further work on GluA2 would involve more shape determining experiments done 
on the dimer. The first would be to use previous work done using SAXS to generate a 
bead model of the dimer and compare the various mutants and the wild type to see how 
the envelope changes. These changes could then be checked against sedimentation 
velocity experiments to ensure their accuracy. 
 
5.3 GluN Future Directions  
 
In chapter 4 we showed how the motions along the principal components of GluN1 and 
GluN2B affect distances between ligand binding domains in the tetramer, and thus how 
these motions may contribute to the function of the receptor. A future analysis is super 
imposing GluN3 onto the GluN1 chains of the full length structure. Although both are 
glycine binding domains, the tetramers they form with the glutamate binding NMDA 
receptors have several differences in receptor properties (Low and Wee 2010). 
Assuming that GluN3 and GluN1 assemble in similar ways with GluN2B, we may be 
able to see if some of these differences are the result of motions along any of the 






Armstrong N, Gouaux E, Mechanisms for Activation and Antagonism of an AMPA-
Sensitive Glutamate Receptor: Crystal Structures of the GluR2 Ligand Binding Core, 
Neuron, Volume 28, Issue 1, 2000, Pages 165-181, ISSN 0896-6273  
 
Bigge CF, Ionotropic glutamate receptors, Current Opinion in Chemical Biology, Volume 
3, Issue 4, 1999, Pages 441-447, ISSN 1367-5931 
 
Bjerrum EJ, Biggin PC. Rigid body essential X-ray crystallography: distinguishing the 
bend and twist of glutamate receptor ligand binding domains. Proteins. 2008;72:434–
446. 
 
Box GEP, Jenkins GM, Reinsel GC. Time series analysis: forecasting and control. 
Hoboken, N.J: John Wiley; 2008. 
 
Boczko EM, Brooks CL III Constant-Temperature Free Energy Surfaces for Physical 
and Chemical Processes. J Phys Chem 1993;97:4509–4513 
 
Brown PH, Schuck P. Macromolecular Size-and-Shape Distributions by Sedimentation 
Velocity Analytical Ultracentrifugation. Biophysical Journal. 2006;90(12):4651-4661. 
doi:10.1529/biophysj.106.081372. 
 
Chaudhry C., Plested A.J.R., Schuck P., Mayer M.L. 2009a. Energetics of glutamate 
receptor ligand binding domain dimer assembly are modulated by allosteric ions. Proc. 
Natl. Acad. Sci. USA.106:12329–12334 
 
Chen GQ, Cui C, Mayer ML and Gouaux E. Functional characterization of a potassium-
selective prokaryotic glutamate receptor Nature 402, 817-821 16 December 1999 
 
Cheng Q, Thiran S, Yernool D, Gouaux E, Jayaraman V. A vibrational spectroscopic 
investigation of interactions of agonists with GluR0, a prokaryotic glutamate receptor. 
Biochemistry. 2002 Feb 5;41(5):1602-8. 
 
Choi YB, Lipton SA Identification and Mechanism of Action of Two Histidine Residues 
Underlying High-Affinity Zn2+ Inhibition of the NMDA Receptor Neuron 1999 Volume 23 
, Issue 1 , 171 – 180 
 
Cole JL, Lary JW, Moody T, Laue TM. Analytical Ultracentrifugation: Sedimentation 
Velocity and Sedimentation Equilibrium. Methods in cell biology. 2008;84:143-179. 
doi:10.1016/S0091-679X(07)84006-4. 
 
Dingledine R, Borges K, Bowie D and Traynelis SF The Glutamate Receptor Ion 




Ferrenberg AM, Swendsen RH Optimized Monte Carlo data analysis. Phys Rev Lett 
1989;63:1195–1198 
 
Fiser A, Do RK, and Sali A. Modeling of loops in protein structures, Protein Science 9. 
1753-1773, 2000. 
 
Franke D, Svergun DI. DAMMIF, a program for rapid ab-initio shape determination in 
small-angle scattering. Journal of Applied Crystallography. 2009;42(Pt 2):342-346. 
doi:10.1107/S0021889809000338 
 
Freire E. Statistical thermodynamic linkage between conformational and binding 
equilibria. Adv Protein Chem. 1998;51:255–279. 
 
Furukawa H, Gouaux E (2003) Mechanisms of activation, inhibition and specificity: 
crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J 22(12): 
2873–2885 
 
Furukawa H. Structure and function of glutamate receptor amino terminal domains. The 
Journal of Physiology. 2012;590(Pt 1):63-72. doi:10.1113/jphysiol.2011.213850. 
 
García AE. Large-amplitude nonlinear motions in proteins. Phys Rev 
Lett. 1992;68:2696–2699. 
 
Gielen M, Retchless BS, Mony L, Johnson JW, Paoletti P. Mechanism of differential 
control of NMDA receptor activity by NR2 subunits. Nature. 2009;459(7247):703-707. 
doi:10.1038/nature07993.  
 
Grant, Rodrigues, ElSawy, McCammon, Caves, Bio3D: An R package for the 
comparative analysis of protein structures. Bioinformatics 2006;22, 2695-2696 
 
Grossfield, A., and Zuckerman, D.M. Quantifying uncertainty and sampling quality in 
biomolecular simulations. Annu. Rep. Comput. Chem. 2009;5, 23–48. 
 
Hansen KB, Yuan H, Traynelis SF. Structural aspects of AMPA receptor activation, 
desensitization and deactivation. Curr Opin Neurobiol. 2007;17:281–288. 
 
Haydyn D.T. Mertens, Dmitri I. Svergun, Structural characterization of proteins and 
complexes using small-angle X-ray solution scattering, Journal of Structural Biology, 
Volume 172, Issue 1, 2010, Pages 128-141, ISSN 1047-8477, 
https://doi.org/10.1016/j.jsb.2010.06.012 
 
Hayward, S., and Berendsen, H.J. Systematic analysis of domain motions in proteins 




Horning MS, Mayer ML (2004) Regulation of AMPA receptor gating by ligand binding 
core dimers. Neuron 41(3):379–388. 
Howlett GJ, Minton AP, Rivas G (2006) Analytical ultracentrifugation for the study of 
protein association and assembly. Curr Opin Chem Biol 10: 430–436. 
 
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders. 
Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous 
System: Workshop Summary. Washington (DC): National Academies Press (US); 2011. 
2, Overview of the Glutamatergic System. 
 
Jacques DA, Trewhella J. Small-angle scattering for structural biology—Expanding the 
frontier while avoiding the pitfalls. Protein Science : A Publication of the Protein Society. 
2010;19(4):642-657. doi:10.1002/pro.351 
 
Karakas E, Regan MC, Furukawa H. Emerging structural insights into the function of 
ionotropic glutamate receptors Trends in Biochemical Sciences Volume 40, Issue 6, 
2015 Pages 328-337 
 
Kästner J Umbrella sampling. WIREs Comput Mol Sci 2011;1(6):932–942  
 
Kaye SL, Sansom MSP, Biggin PC. Molecular dynamics simulations of the ligand-
binding domain of an N-methyl-D-aspartate receptor. J Biol Chem. 2006;281:12736–
12742.  
 
Kikhney Alexey G. and Svergun Dmitri I. (2015), A practical guide to small angle X-ray 
scattering (SAXS) of flexible and intrinsically disordered proteins, FEBS Letters, 589, 
doi: 10.1016/j.febslet.2015.08.027 
 
Kirkwood JG Statistical mechanics of fluid mixtures. J Chem Phys 1935;3:300 
 
Krieger J, Bahar I, Greger IH. Structure, Dynamics, and Allosteric Potential of Ionotropic 
Glutamate Receptor N-Terminal Domains. Biophysical Journal. 2015;109(6):1136-1148. 
doi:10.1016/j.bpj.2015.06.061. 
 
Kumar S, Bouzida D, Swendsen RH, Kollman PA, Rosenberg JM The weighted 
histogram analysis method for free-energy calculations on biomolecules. I. The method. 
J Comp Chem 19923;13:1011–1021 
 
Lebowitz J, Lewis MS, Schuck P. Modern analytical ultracentrifugation in protein 
science: A tutorial review. Protein Science : A Publication of the Protein Society. 
2002;11(9):2067-2079. 
 
Lee, J.H., Kang, G.B., Lim, H.H., Jin, K.S., Kim, S.H., Ree, M., Park, C.S., Kim, S.J., 
and Eom, S.H. (2008). Crystal structure of the GluR0 ligand-binding core from Nostoc 
punctiforme in complex with L-glutamate: structural dissection of the ligand interaction 
108 
 
and subunit interface. J. Mol. Biol. 376, 308–316. 
 
Lee C-H, Lü W, Michel JC, et al. NMDA receptor structures reveal subunit arrangement 
and pore architecture. Nature. 2014;511(7508):191-197. doi:10.1038/nature13548. 
 
Levy, R.M., Srinivasan, A.R., Olson, W.K., and McCammon, J.A. Quasiharmonic 
method for studying very low frequency modes in proteins. Biopolymers 1984;23, 1099–
1112 
 
Low CM, Zheng F, Lyuboslavsky P, Traynelis SF Molecular determinants of coordinated 
proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors Proceedings of 
the National Academy of Sciences Sep 2000, 97 (20) 11062-
11067; DOI:10.1073/pnas.180307497 
 
Low, CM, Wee, KS (2010) New insights into the not-so-new NR3 subunits of N-methyl-
d-aspartate receptor: localization, structure, and function. Mol Pharmacol 78:1–11. 
 
Ma B, Kumar S, Tsai CJ, Nussinov R. Folding funnels and binding mechanisms. Protein 
Eng. 1999;12:713–720 
 
Mayer ML, Olson R, Gouaux E, Mechanisms for ligand binding to GluR0 ion channels: 
crystal structures of the glutamate and serine complexes and a closed apo state Journal 
of Molecular Biology, Volume 311, Issue 4, 2001, Pages 815-836, ISSN 0022-2836, 
https://doi.org/10.1006/jmbi.2001.4884. 
 
Mayer ML. Emerging models of glutamate receptor ion channel structure and function. 
Structure. 2011;19:1370–1380 
 
Meyerson JR, Kumar J, Chittori S, et al. Structural mechanism of glutamate receptor 
activation and desensitization. Nature. 2014;514(7522):328-334. 
doi:10.1038/nature13603. 
 
Meng, Y.; Shukla, D.; Pande, V. S.; Roux, B. Transition Path Theory Analysis of c-Src 
Kinase Activation Proc. Natl. Acad. Sci. U. S. A. 2016, 113, 9193– 9198 DOI: 
10.1073/pnas.1602790113S 
 
Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible 
model. J Mol Biol. 1965;12:88–118 
 
Pøhlsgaard J, Frydenvang K, Madsen U, Kastrup JS. Lessons from more than 80 
structures of the GluA2 ligand-binding domain in complex with agonists, antagonists 
and allosteric modulators. Neuropharmacology. 2011;60:135–150. 
 
Purves D, Augustine GJ, Fitzpatrick D, et al., editors. Neuroscience. 2nd edition. 




Ptak CP, Hsieh C-L, Weiland GA, Oswald RE. Role of Stoichiometry in the Dimer-
Stabilizing Effect of AMPA Receptor Allosteric Modulators. ACS Chemical Biology. 
2014;9(1):128-133. doi:10.1021/cb4007166. 
 
Roux B The calculation of the potential of mean force using computer simulations. 
Comput Phys Commun 1995;91:275–282 
 
Sali A amd Blundell TL. Comparative protein modelling by satisfaction of spatial 
restraints. J. Mol. Biol. 234, 779-815, 1993. 
 
Schauder DM, Kuybeda O, Zhang J, et al. Glutamate receptor desensitization is 
mediated by changes in quaternary structure of the ligand binding domain. Proceedings 
of the National Academy of Sciences of the United States of America. 
2013;110(15):5921-5926. doi:10.1073/pnas.1217549110. 
 
Schneidman-Duhovny D, Hammel M, Tainer JA, and Sali A. Accurate SAXS profile 
computation and its assessment by contrast variation experiments. Biophysical Journal 
2013. 105 (4), 962-974  
 
Schneidman-Duhovny D, Hammel M, Tainer JA, and Sali A. FoXS, FoXSDock and 
MultiFoXS: Single-state and multi-state structural modeling of proteins and their 
complexes based on SAXS profiles NAR 2016 
 
Shepherd J.D., Huganir R.L. The cell biology of synaptic plasticity: AMPA receptor 
trafficking. Annu. Rev. Cell Dev. Biol. 2007;23:613–643 
 
Stawski P, Janovjak H, Trauner D. Pharmacology of ionotropic glutamate receptors: A 
structural perspective. Bioorg Med Chem. 2010;18:7759–7772. 
 
Svergun DI. Restoring low resolution structure of biological macromolecules from 
solution scattering using simulated annealing. Biophysical Journal. 1999;76(6):2879-
2886. 
 
Torrie GM, Valleau JP Monte-Carlo free energy estimates using non-Boltzmann 
sampling. Application to the subcritical Lennard-Jones fluid. Chem Phys Lett 
1974;28(4):578–581 
 
Wang Q, Canutescu AA, Dunbrack RL. SCWRL and MolIDE: Computer programs for 
side-chain conformation prediction and homology modeling. Nature protocols. 
2008;3(12):1832-1847. doi:10.1038/nprot.2008.184. 
 
Weston M.C., Schuck P., Ghosal A., Rosenmund C., Mayer M.L. 2006. Conformational 





Yalini A, Biggin PC, Shrivastava IH. and Sansom M A prokaryotic glutamate receptor: 
homology modelling and molecular dynamics simulations of GluR0 2003 FEBS Letters, 
553, 
 
Yao Y, Belcher J, Berger AJ, Mayer ML, Lau AY, Conformational Analysis of NMDA 
Receptor GluN1, GluN2, and GluN3 Ligand-Binding Domains Reveals Subtype-Specific 
Characteristics, Structure, Volume 21, Issue 10, 2013, Pages 1788-1799, ISSN 0969-
2126, https://doi.org/10.1016/j.str.2013.07.011. 
 
Yu A and Lau AY Energetics of Glutamate Binding to an Ionotropic Glutamate Receptor 
The Journal of Physical Chemistry B 2017 121 (46), 10436-10442 
 
Yuan H, Hansen KB, Vance KM, Ogden KK, Traynelis SF. Control of N-methyl-D-
aspartate Receptor Function by the NR2 Subunit Amino-Terminal Domain. The Journal 
of neuroscience : the official journal of the Society for Neuroscience. 
2009;29(39):12045-12058. doi:10.1523/JNEUROSCI.1365-09.2009. 
 
Zhu F, Hummer G. Convergence and error estimation in free energy calculations using 






3601 Greenway #908, Baltimore, MD 21218 | 210-831--8897 | jbelche1@jhu.edu 
EDUCATION 
Johns Hopkins School of Medicine Baltimore MD 
PhD in Molecular Biophysics 2018 
Dissertation: “Computational and Experimental Analysis of Glutamate Receptor Ligand Binding Domains” 
 
University of Texas at San Antonio 




Francis D. Carlson Fellowship 2010 – 2012 
GEBS Summer Scholar 2009 
Ronald E. McNair Scholar 2008 – 2009 
PRESENTATIONS 
Computational and Experimental Studies of a Prokaryotic Glutamate Receptor 
Platform speaker at 60th Annual Meeting of the Biophysical Society 2016 
Principal Component Analysis of Glutamate Receptor Ligand Binding Domains 
Poster presented at 58th Annual Meeting of the Biophysical Society 2014 
Molecular Mechanisms of Glutamate Receptor Activation and Regulation 
Poster presented at 57th Annual Meeting of the Biophysical Society 2013 
Molecular Mechanisms of Glutamate Receptor Activation and Regulation 
Poster presented at HHMI Conference on Structural Biology of Membrance Proteins 2013 
Structural Thermodynamics of NMDA Receptor Ligand Binding Domains  
Poster presented at 56th Annual Meeting of the Biophysical Society 2012 
PUBLICATIONS 
Yu A, Weid T, Belcher J, Lau AY. (2015) ”Computing Conformational Free Energies of 
iGluR Ligand-Binding Domains.” In: Ionotropic Glutamate Receptor Technologies., Popescu 
GK ed., NeuroMethods Springer pg. 119-132 
Yao Y*, Belcher J*, Berger AJ, Mayer ML, Lau AY. (2013) Conformational Analysis of 
NMDA Receptor GluN1, GluN2, and GluN3 Ligand-Binding Domains Reveals Subtype-
Specific Characteristics. Structure. Oct 8;21(10) pg. 1788-1799. PMID: 23972471 
Valdez R, Johnson EM, Belcher J, Fuini JF, Brancaleon L. (2009) Porphyrins Affect The 
Self-Assembly of Tubulin in Solution. Biophysical Chemistry. Dec;145(2-3) pg. 98-104. 
PMID: 19819610 
Belcher J, Sansone S, Fernandez NF, Haskins WE and Brancaleon L. (2009) Photoinduced 
Unfolding of Lactoglobulin Mediated by a Water-Soluble Porphyrin. J. Phys. Chem. B. Apr 
30;113 pg. 6020-30. PMID: 1935116 
*denotes equal contribution to authorship 
MEMBERSHIPS 
Biophysical Society 
 
